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Abstract
We present a SIR+ASI epidemic model to describe the interaction between human and
dengue fever mosquito populations. A control strategy in the form of vaccination, to decrease
the number of infected individuals, is used. An optimal control approach is applied in order to
find the best way to fight the disease.
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1 Introduction
Dengue fever is a vector borne disease, which has become an increasingly public health problem
that carries a huge financial burden to the governments. Currently, the only way of controlling the
disease is to minimize the vector population. Dengue vaccine for effective prevention and long term
control under development, is expected to be the solution. Dengue transcends international borders
and is emerging rapidly as a consequence of globalization and climate changes. It is a disease of great
complexity, due to the interactions between humans, mosquitoes, and various virus serotypes as well
as efficient vector survival strategies. The four serotypes, known as DEN1 to DEN4, constitute a
complex of flaviviridae transmitted by Aedes mosquitos, specially Aedes Aegypti. Infection by any of
the four serotypes induces lifelong immunity against reinfection by the same type, but only partial
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and temporary protection against the others. Sequential infection by different serotypes could lead
to a more severe dengue episode: dengue hemorrhagic fever (DHF).
Vector control remains the only available strategy against dengue. Despite integrated vector
control with community participation, along with active disease surveillance and insecticides, there
are only a few examples of successful dengue prevention and control on a national scale [1]. To make
matters worse, the levels of resistance of Aedes Aegypti to insecticides has increased, which imply
shorter intervals between treatments, and only few insecticide products are available in the market
because of high costs for development and registration and low returns.
For long time, the evaluation of global dengue disease burden was limited and the stakeholders
considered the potential market for the dengue vaccine to be small. By the end of 20th century, with
the increase in dengue infections as well as the prevalence of all four circulating serotypes, faster
development of a vaccine became a serious concern [2]. It is agreed that a vaccination program
not only protects directly the individual, but also indirectly the population, which is called herd
immunity. As a consequence of vaccination, the occurrence of epidemics would decrease relieving
health facilities. However, constructing a successful vaccine for dengue has been challenging. Not
only is the knowledge of disease pathogenesis insufficient, but also the vaccine must protect against
all serotypes so that the level of DHF doesn’t increase.
2 Optimal control of the epidemiological model
Two types of population were considered: hosts and vectors. The hosts (humans) are divided into
three complementary classes: susceptible, Sh(t), individuals who can contract the disease; infected,
Ih(t), individuals capable of transmitting the disease to others; and resistant, Rh(t), individuals
who have acquired immunity at time t. The total number of hosts is constant, which means that
Nh = Sh(t) + Ih(t) + Rh(t). Similarly, the model has also three compartments for the vectors
(mosquitoes): Am(t), which represents the aquatic phase of the mosquito (including egg, pupae
and larvae) and the adult phase of the mosquito, with Sm(t) and Im(t), susceptible and infected,
respectively. It is also assumed that Nm = Sm(t)+Im(t). The model is described by an initial value
problem with a system of six differential equations:


dSh
dt
= µhNh −
(
Bβmh
Im
Nh
+ µh + u
)
Sh + σuRh
dIh
dt
= Bβmh
Im
Nh
Sh − (ηh + µh)Ih
dRh
dt
= ηhIh + uSh − (σu+ µh)Rh
dAm
dt
= ϕ
(
1− Am
kNh
)
(Sm + Im)− (ηA + µA)Am
dSm
dt
= ηAAm −
(
Bβhm
Ih
Nh
+ µm
)
Sm
dIm
dt
= Bβhm
Ih
Nh
Sm − µmIm.
(1)
The recruitment rate of human population is noted by µhNh. The natural death rate for humans and
mosquitoes, aquatic and adult phase, is described by the parameters µh, µm and µA, respectively.
We assume that B is the average daily biting (per day) of the mosquito whereas βmh and βhm are
related to the transmission probability (per bite) from infected mosquitoes to humans and vice versa.
By ϕ we denote the number of eggs at each deposit per capita (per day). The recovery rate of the
human population is denoted by ηh. The maturation rate from larvae to adult (per day) is denoted
by ηA. The vaccine coverage of the susceptible is represented by u (the control variable). The factor
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σ represents the level of inefficacy of the vaccine: for σ = 0 the vaccine is perfectly effective, while
σ = 1 means that the vaccine has no effect at all. The main aim of this work is to study the optimal
vaccination strategy considering both the costs of treatment of infected individuals and the costs of
vaccination. So, the objective functional is
minimize J [u] =
∫ tf
0
[
γIIh(t)
2 + γV u(t)
2
]
dt, (2)
where γI and γV are positive constants representing the weights of the costs of treatment of infected
and vaccination, respectively. Let λi(t), with i = 1, . . . , 6, be the co-state variables. The Hamiltonian
for the present optimal control problem is given by
H = λ1
[
µhNh −
(
Bβmh
Im
Nh
+ µh + u
)
Sh + σuRh
]
+ λ2
[
Bβmh
Im
Nh
Sh − (ηh + µh) Ih
]
+ λ3 [ηhIh + uSh − (σu+ µh)Rh] + λ4
[
ϕ
(
1−
Am
kNh
)
(Sm + Im)− (ηA + µA)Am
]
+ λ5
[
ηAAm −
(
Bβhm
Ih
Nh
+ µm
)
Sm
]
+ λ6
[
Bβhm
Ih
Nh
Sm − µmIm
]
+ γII
2
h + γV u
2.
(3)
By the Pontryagin maximum principle [3], the optimal control u∗ should be the one that minimizes,
at each instant t, the Hamiltonian given by (3), that is,
H (x∗(t), λ∗(t), u∗(t)) = min
u∈[0,1]
H (x∗(t), λ∗(t), u) .
The optimal control, derived from the stationary condition ∂H
∂u
= 0 and considering 0 ≤ u ≤ 1, is
given by
u∗ = min
{
1,max
{
0,
(λ1 − λ3) (Sh − σRh)
2γV
}}
.
Substituting the optimal control u∗ into the state system (1) and the adjoint system λ
′
i(t) = −
∂H
∂xi
,
i.e., 

dλ1
dt
= (λ1 − λ2)
(
Bβmh
Im
Nh
)
+ λ1µh + (λ1 − λ3)u
dλ2
dt
= −2γIIh + λ2(ηh + µh)− λ3ηh + (λ5 − λ6)
(
Bβhm
Sm
Nh
)
dλ3
dt
= −λ1σu+ λ3(µh + σu)
dλ4
dt
= λ4ϕ
Sm+Im
kNh
+ λ4(ηA + µA)− λ5ηA
dλ5
dt
= −λ4ϕ
(
1− Am
kNh
)
+ (λ5 − λ6)Bβhm
Ih
Nh
+ λ5µm
dλ6
dt
= (λ1 − λ2)
(
Bβmh
Sh
Nh
)
− λ4ϕ
(
1− Am
kNh
)
+ λ6µm,
we obtain the corresponding x∗ and λ∗i , i = 1, . . . 6, with the help of the transversality conditions
λ∗i (tf ) = 0, i = 1, . . . , 6 (see [3] for details).
3 Numerical simulation and discussion
The simulations were carried out using the following values: Nh = 480000, B = 0.5, βmh = 0.3,
βhm = 0.3, µh = 1/(71 × 365), ηh = 1/3, µm = 1/10, k = 3, m = 3, Nm = m × Nh, ϕ = 6, and
3
Method optimal control no control (u ≡ 0) upper control (u ≡ 1)
Direct (DOTcvpSB) 0.146675 0.674555 364.940488
Indirect (backward-forward) 0.113137 0.357285 365.00046
Table 1: Values of the cost functional (2)
tf = 365 days. It was considered that the vaccine is imperfect with a level of inefficacy of σ = 0.15.
The initial conditions for the ordinary differential system were: Sh(0) = Nh − 216, Ih(0) = 216,
Rh(0) = 0, Am = k∗Nh, Sm(0) = Nm and Im(0) = 0. The optimal control problem was solved using
two methods: direct and indirect. For an introduction to direct and indirect methods in optimal
control we refer the reader to [4, 5]. The direct method uses the optimal functional (2) and the state
system (1) and was solved by DOTcvpSB [6]. It is a toolbox implemented in MatLab, which uses
an ensemble of numerical methods for solving continuous and mixed-integer dynamic optimization
problems. The indirect method we used is an iterative method with a Runge–Kutta scheme, solved
through ode45 of MatLab. The state system with an initial guess is solved forward in time and
then the adjoint system with the transversality conditions is solved backward in time. The controls
are updated at the end of each iteration (see [7] for more details). Figure 1 shows the optimal
control obtained by the two different approaches. They both seem to have the same behavior.
Figure 1: Optimal control with direct and indirect
approaches.
Figure 2: Infected humans using different levels of
control.
Table 1 shows the costs obtained by the two methods, in three situations: optimal control, no
control (u(t) ≡ 0) and upper control (u(t) ≡ 1). Figure 2 shows the number of infected humans
when different controls are considered. It is possible to see that the upper control, which means
that everyone is vaccinated, implies that just a few individuals were infected, allowing eradication of
the disease. Although the optimal control, in the sense of objective (2), allows the occurrence of an
outbreak, the number of infected individuals is much lower when compared with a situation where
no one is vaccinated. Also, the costs are very low when compared with the upper control case.
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4 Conclusions
Dengue is an infectious tropical disease difficult to prevent and manage. Researchers agree that the
development of a vaccine for dengue is a question of high priority. In the present study we show how
a vaccine results in saving lives and at the same time in a reduction of the budget related with the
disease. As future work we intend to study the interaction of a dengue vaccine with other kinds of
control already investigated in the literature, such as insecticide and educational campaigns [8, 9].
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